{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T18:54:20Z","timestamp":1794682460005,"version":"4.9.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Gansu Provincial Hospital","award":["21GSSYC-45 and 21GSSYA-9"],"award-info":[{"award-number":["21GSSYC-45 and 21GSSYA-9"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,9]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Noonan syndrome (NS) is a RASopathy most frequently associated with mutations in HRAS, NRAS, KRAS, and RRAS2. The contribution of MRAS variants to NS pathogenesis remains poorly characterized, and infective endocarditis (IE) is extremely rare in patients with NS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 22-year-old woman presented with typical dysmorphic features of NS, including short stature, broad forehead, hypertelorism, low-set posteriorly rotated ears, and a broad neck. She developed fever and progressive exertional dyspnea.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Echocardiography demonstrated obstructive hypertrophic cardiomyopathy with vegetation located in the left ventricular outflow tract. Blood cultures grew Streptococcus mutans. Whole-exome sequencing identified a heterozygous MRAS c.203C&gt;T (p.Thr68Ile) mutation affecting a highly conserved residue among RASopathy-associated GTPases, supporting the diagnosis of MRAS-associated Noonan syndrome complicated by infective endocarditis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Antibiotic therapy was escalated to intravenous gentamicin (60 mg daily) combined with ceftriaxone in accordance with the 2023 European Society of Cardiology guidelines for infective endocarditis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>After one month of intravenous gentamicin and ceftriaxone therapy, fever resolved, and follow-up echocardiography showed disappearance of the vegetation. Residual cardiac abnormalities persisted, including marked left ventricular hypertrophy with left ventricular outflow tract obstruction, left atrial enlargement, moderate mitral regurgitation, patent foramen ovale with minor shunting, and impaired diastolic function. Exertional dyspnea remained despite resolution of the infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case expands the genotypic spectrum of Noonan syndrome by supporting MRAS mutations as pathogenic drivers. It also identifies infective endocarditis as a previously unreported complication in MRAS-associated NS with outflow tract obstruction, highlighting the importance of careful cardiac surveillance in patients with RASopathies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000046340","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:02:02Z","timestamp":1767988922000},"page":"e46340","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Novel characterization of MRAS mutation-associated Noonan syndrome: Mild adult-onset hypertrophic cardiomyopathy combined with infective endocarditis: A case report"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5841-6656","authenticated-orcid":false,"given":"Xiaoli","family":"Mou","sequence":"first","affiliation":[{"name":"Gansu Provincial Hospital, Lanzhou, Gansu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[{"name":"Gansu Provincial Hospital, Lanzhou, Gansu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yarong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Gansu Provincial Hospital, Lanzhou, Gansu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhe","family":"Cheng","sequence":"additional","affiliation":[{"name":"Gansu Provincial Hospital, Lanzhou, Gansu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junshuai","family":"Feng","sequence":"additional","affiliation":[{"name":"Gansu Provincial Hospital, Lanzhou, Gansu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260805","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(12)61023-X","article-title":"Noonan syndrome.","volume":"381","author":"Roberts","year":"2013","journal-title":"Lancet (London, England)"},{"key":"R2-20260805","doi-asserted-by":"crossref","first-page":"e91225","DOI":"10.1172\/jci.insight.91225","article-title":"Elucidation of MRAS-mediated Noonan syndrome with cardiac hypertrophy.","volume":"2","author":"Higgins","year":"2017","journal-title":"JCI insight"},{"key":"R3-20260805","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/jmg.24.1.9","article-title":"Noonan syndrome.","volume":"24","author":"Allanson","year":"1987","journal-title":"J Med Genet"},{"key":"R4-20260805","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/1096-8628(20000904)94:1<46::AID-AJMG10>3.0.CO;2-I","article-title":"Genetic heterogeneity in Noonan syndrome: evidence for an autosomal recessive form.","volume":"94","author":"van Der Burgt","year":"2000","journal-title":"Am J Med Genet"},{"key":"R5-20260805","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0022-3476(99)70088-0","article-title":"Congenital heart diseases in children with Noonan syndrome: an expanded cardiac spectrum with high prevalence of atrioventricular canal.","volume":"135","author":"Marino","year":"1999","journal-title":"J Pediatr"},{"key":"R6-20260805","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0735-1097(93)90436-5","article-title":"Cardiologic abnormalities in Noonan syndrome: phenotypic diagnosis and echocardiographic assessment of 118 patients.","volume":"22","author":"Burch","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"R7-20260805","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/archdischild-2013-305047","article-title":"Cardiovascular disease in Noonan syndrome.","volume":"99","author":"Prendiville","year":"2014","journal-title":"Arch Dis Child"},{"key":"R8-20260805","doi-asserted-by":"crossref","first-page":"e1325","DOI":"10.1542\/peds.2006-0211","article-title":"The spectrum of cardiac anomalies in Noonan syndrome as a result of mutations in the PTPN11 gene.","volume":"119","author":"Sznajer","year":"2007","journal-title":"Pediatrics"},{"key":"R9-20260805","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.110.985812","article-title":"Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy.","volume":"124","author":"Maron","year":"2011","journal-title":"Circulation"},{"key":"R10-20260805","doi-asserted-by":"crossref","first-page":"e4008","DOI":"10.1097\/MD.0000000000004008","article-title":"Infective endocarditis in hypertrophic cardiomyopathy: a multicenter, prospective, cohort study.","volume":"95","author":"Dominguez","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R11-20260805","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"R12-20260805","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.xjtc.2020.10.046","article-title":"Commentary: Endocarditis in hypertrophic cardiomyopathy: a reason to strengthen the guidelines?","volume":"4","author":"Carrel","year":"2020","journal-title":"JTCVS Techniques"},{"key":"R13-20260805","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/10409238.2018.1431605","article-title":"Structural fingerprints, interactions, and signaling networks of RAS family proteins beyond RAS isoforms.","volume":"53","author":"Nakhaei-Rad","year":"2018","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"Pt 5","key":"R14-20260805","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1242\/jcs.01660","article-title":"The RAS superfamily at a glance.","volume":"118","author":"Wennerberg","year":"2005","journal-title":"J Cell Sci"},{"key":"R15-20260805","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/hmg\/ddz108","article-title":"Activating MRAS mutations cause Noonan syndrome associated with hypertrophic cardiomyopathy.","volume":"29","author":"Motta","year":"2020","journal-title":"Hum Mol Genet"},{"key":"R16-20260805","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1002\/ajmg.a.61261","article-title":"Severe Noonan syndrome phenotype associated with a germline Q71R MRAS variant: a recurrent substitution in RAS homologs in various cancers.","volume":"179","author":"Suzuki","year":"2019","journal-title":"Am J Med Genet A"},{"key":"R17-20260805","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1002\/ajmg.a.62376","article-title":"Atypical, severe hypertrophic cardiomyopathy in a newborn presenting Noonan syndrome harboring a recurrent heterozygous MRAS variant.","volume":"185","author":"Pires","year":"2021","journal-title":"Am J Med Genet A"},{"key":"R18-20260805","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ajmg.c.32034","article-title":"Natural history of MRAS-related Noonan syndrome: evidence of mild adult-onset left ventricular hypertrophy and neuropsychiatric features.","volume":"193","author":"Priolo","year":"2023","journal-title":"Am J Med Genet C Semin Med Genet"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000046340","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T17:02:50Z","timestamp":1785949370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000046340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046340","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"2025-04-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}